Related Experiment Videos
CREB-binding protein activates transcription through multiple domains
D L Swope1, C L Mueller, J C Chrivia
1Department of Pharmacological and Physiological Sciences, Saint Louis University School of Medicine, St. Louis, Missouri 63104, USA.
The Journal of Biological Chemistry
|November 8, 1996
Summary
The N-terminal half of CREB-binding protein (CBP) contains a transcriptional activation domain (TAD) sufficient for CREB-mediated transcription. This domain binds TBP and its activity is cell-type specific in response to PKA.
Area of Science:
- Molecular Biology
- Gene Regulation
- Protein Function
Background:
- CREB-binding protein (CBP) is a coactivator for various transcription factors.
- The specific regions of CBP responsible for transcriptional activation were previously unidentified.
Purpose of the Study:
- To identify and characterize the transcriptional activation domains (TADs) within CBP.
- To investigate the interaction of CBP TADs with TATA-binding protein (TBP).
- To determine the cell-type specificity of PKA-mediated regulation of CBP TADs.
Main Methods:
- Deletion analysis to identify functional domains within CBP.
- Squelching assays to assess the role of TADs in transcription.
- In vitro binding assays to examine CBP TAD-TBP interactions.
- GAL-CBP chimera constructs to study C-terminal TADs.
- Reporter gene assays in various cell lines (PC-12, F9, COS-7) to assess transcriptional activity.
Main Results:
- The N-terminal half of CBP possesses a potent TAD sufficient for CREB-mediated transcription.
- This N-terminal TAD directly binds TBP.
- Two distinct C-terminal TADs were identified adjacent to the c-Fos binding site.
- PKA enhances the transcriptional activity of the N-terminal TADs in PC-12 cells, but not in F9 or COS-7 cells, indicating cell-type specific regulation.
Conclusions:
- CBP contains multiple TADs, with the N-terminal region being crucial for CREB-mediated transcription and TBP binding.
- The regulation of CBP activity by PKA is cell-type specific.
- These findings elucidate the functional organization of CBP's transcriptional activation capabilities.